Botulinum toxin treatment failures in cervical dystonia: causes, management, and outcomes

The spread of primary late-onset focal dystonia in a long-term follow up study

(2015) Marina Svetel et al.   CLINICAL NEUROLOGY AND NEUROSURGERY

Practical guidance for CD management involving treatment of botulinum toxin: a consensus statement

(2015) Alberto Albanese et al.   JOURNAL OF NEUROLOGY

An international survey of patients with cervical dystonia

(2015) Cynthia Comella et al.   JOURNAL OF NEUROLOGY

Primary results from the Cervical Dystonia Patient Registry for Observation of OnabotulinumtoxinA Efficacy (CD PROBE)

(2015) Joseph Jankovic et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Factors influencing secondary non-response to botulinum toxin type A injections in cervical dystonia

(2015) Joaquim J. Ferreira et al.   PARKINSONISM & RELATED DISORDERS

An 18F-FDG PET study of cervical muscle in parkinsonian anterocollis

(2014) Gonzalo J. Revuelta et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

The focal dystonias: Current views and challenges for future research

(2013) H. A. Jinnah et al.   MOVEMENT DISORDERS

Phenomenology and classification of dystonia: A consensus update

(2013) Alberto Albanese et al.   MOVEMENT DISORDERS

Cervical dystonia: Improved treatment response to botulinum toxin after referral to a tertiary centre and the use of polymyography

(2013) S.W.R. Nijmeijer et al.   PARKINSONISM & RELATED DISORDERS

Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders

(2013) Mark Hallett et al.   TOXICON

Continuation of Long-Term Care for Cervical Dystonia at an Academic Movement Disorders Clinic

(2013) Chandler Gill et al.   Toxins

Immunogenicity and Long-Term Efficacy of Botulinum Toxin Type B in the Treatment of Cervical Dystonia

(2012) Robert B. Chinnapongse et al.   CLINICAL NEUROPHARMACOLOGY

Immunoresistance in Cervical Dystonia Patients After Treatment With AbobotulinumtoxinA

(2012) Chandra Coleman et al.   INTERNATIONAL JOURNAL OF NEUROSCIENCE

Immunogenicity of botulinum toxins

(2012) Markus Naumann et al.   JOURNAL OF NEURAL TRANSMISSION

Age at onset and symptom spread in primary adult-onset blepharospasm and cervical dystonia

(2012) Davide Martino et al.   MOVEMENT DISORDERS

Factors influencing response to Botulinum toxin type A in patients with idiopathic cervical dystonia: results from an international observational study

(2012) Vijay P Misra et al.   BMJ Open

Clinical subtypes of anterocollis in parkinsonian syndromes

(2011) Gonzalo J. Revuelta et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Anterior and posterior sagittal shift in cervical dystonia: A clinical and electromyographic study, including a new EMG approach of the longus colli muscle

(2011) Joanna M. Flowers et al.   MOVEMENT DISORDERS

Treatment of complex cervical dystonia with botulinum toxin: Involvement of deep-cervical muscles may contribute to suboptimal responses

(2011) Roongroj Bhidayasiri   PARKINSONISM & RELATED DISORDERS

Satisfaction with botulinum toxin treatment: a cross-sectional survey of patients with cervical dystonia

(2011) Kapil D. Sethi et al.   JOURNAL OF MEDICAL ECONOMICS

Evolution of dose and response to botulinum toxin A in cervical dystonia: a multicenter study

(2010) Pedro J. Garcia Ruiz et al.   JOURNAL OF NEUROLOGY

Neutralizing Antibodies and Secondary Therapy Failure After Treatment With Botulinum Toxin Type A

(2009) Oliver Lange et al.   CLINICAL NEUROPHARMACOLOGY

Fluoroscopic, EMG-guided injection of botulinum toxin into the longus colli for the treatment of anterocollis

(2009) Graham A. Glass et al.   PARKINSONISM & RELATED DISORDERS

Long-term treatment with botulinum toxin type A in cervical dystonia has low immunogenicity by mouse protection assay

(2008) Mitchell F. Brin et al.   MOVEMENT DISORDERS